Is Theranos' Elizabeth Holmes Really Winning the PR War?

Out for blood? Yes, the media is. Well, most of them.


This is a question bemoaning the PRNewserverse lately.

Here’s a young woman — stress, young — who, at 19, created a company set to revolutionize health care. She dropped out of Stanford pre-med because she had an idea. The idea was in stealth mode for a decade. And today, at 31, she and the idea are worth billions. Nine, in fact.

The idea was Theranos, a medical incubator set out to transform blood testing and dramatically lower prices in the industry.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in